1. Ator N and Kautz M (2000) Differentiating benzodiazepine and — barbiturate — like discriminative stimulus effects of lorazepam, diazepam, pentobarbital, imidazenil and zaleplon in two-versus three-lever procedures. Behavioural Pharmacology 11: 1–14
2. Busto U, Naranjo C, Bremner K, Peachey J, Bologa M (1998) Safety of ipsapirone treatment compared with lorazepam: discontinuation effects. J Psychiatry Neurosci 23: 35–44
3. Dautzenberg F, Wichmann J, Higelin J, Py-Lang G, Kratzeisen C, Malherbe P, Kilpatrick G, Jenck F (2001) Pharmacological characterization of the novel nonpeptide orphanin FQ/noci-ceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo. The Journal of Pharmacology and Experimental Therapeutics 298: 812–819
4. DeVane C (2000) Pharmacologic characteristics of ideal antidepressants in the 21st century. J Clin Psychiatry 61(Suppl 11): 4–8
5. Helmuth L (2000) An antibiotic to treat Alzheimer’s. Science 290: 1273–1274